GlassScriptPhysician profile
Alexis Gil
NPI 1881191807
$5,379.76
in general payments reported to CMS, 2019-2025
26 companies · $909 in 2025
The $909 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $66.02 · 2022: $1,547 · 2023: $303 · 2024: $2,555 · 2025: $909.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,036 · Travel and Lodging: $1,594 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,035.62 |
| Travel and Lodging | $1,594.16 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,262.59 | 2024-2025 | |
| Medical Device Business Services, INC. | $1,677.90 | 2022-2025 | Vistaseal |
| Janssen Pharmaceuticals, INC | $224.43 | 2022-2024 | Xarelto |
| Lexicon Pharmaceuticals, INC. | $145.18 | 2023-2024 | Inpefa |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $98.25 | 2024-2025 | Lifevest |
| Inspire Medical Systems, INC. | $96.31 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $92.30 | 2023-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $81.00 | 2023-2024 | |
| Davol INC. | $80.91 | 2025 | Phasix Mesh |
| Pfizer INC. | $79.31 | 2022-2024 | |
| Biotronik INC. | $70.92 | 2022-2025 | Renamic Neo |
| Ethicon US, LLC | $66.02 | 2021 | |
| Novo Nordisk INC | $63.22 | 2023-2025 | Ozempic, Rybelsus |
| Medtronic, INC. | $48.41 | 2022-2024 | Linq II |
| Kiniksa Pharmaceuticals International, Plc | $47.22 | 2024 | Arcalyst |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $36.08 | 2024-2025 | General - Therapies |
| Hologic Sales and Service, LLC | $30.54 | 2023 | Coolseal Generator |
| Alnylam Pharmaceuticals INC. | $28.76 | 2024 | Onpattro |
| Kestra Medical Technology Services, INC. | $25.47 | 2025 | Assure Wcd |
| Axonics, INC. | $21.64 | 2024 | Axonics |
| Baxter Healthcare | $19.43 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Irhythm Technologies, INC. | $18.82 | 2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $18.35 | 2023 | |
| Sanofi-Aventis U.S. LLC | $18.08 | 2023 | |
| Dexcom, INC. | $14.76 | 2025 | Dexcom G6 Transmitter |
| Zoll Circulation INC | $13.86 | 2023 | Catheter, Downstream Cartridge, Therox Ds2 Console |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Gil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.